Cargando…
Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082045/ http://dx.doi.org/10.1186/1939-4551-7-S1-P11 |
| _version_ | 1782324194028027904 |
|---|---|
| author | Costa, Ana Célia Duarte, Fátima Pedro, Elisa Melo, Alcinda Barbosa, Manuel Pereira Santos, Conceição |
| author_facet | Costa, Ana Célia Duarte, Fátima Pedro, Elisa Melo, Alcinda Barbosa, Manuel Pereira Santos, Conceição |
| author_sort | Costa, Ana Célia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4082045 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | World Allergy Organization |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40820452014-09-11 Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months Costa, Ana Célia Duarte, Fátima Pedro, Elisa Melo, Alcinda Barbosa, Manuel Pereira Santos, Conceição World Allergy Organ J Poster Presentation World Allergy Organization 2014-02-03 /pmc/articles/PMC4082045/ http://dx.doi.org/10.1186/1939-4551-7-S1-P11 Text en Copyright © 2014 Costa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Costa, Ana Célia Duarte, Fátima Pedro, Elisa Melo, Alcinda Barbosa, Manuel Pereira Santos, Conceição Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| title | Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| title_full | Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| title_fullStr | Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| title_full_unstemmed | Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| title_short | Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| title_sort | poster 1020: efficacy and safety of sublingual specific immunotherapy with pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082045/ http://dx.doi.org/10.1186/1939-4551-7-S1-P11 |
| work_keys_str_mv | AT costaanacelia poster1020efficacyandsafetyofsublingualspecificimmunotherapywithprup3inaportuguesepopulationclinicalandimmunologicalevaluationduring12months AT duartefatima poster1020efficacyandsafetyofsublingualspecificimmunotherapywithprup3inaportuguesepopulationclinicalandimmunologicalevaluationduring12months AT pedroelisa poster1020efficacyandsafetyofsublingualspecificimmunotherapywithprup3inaportuguesepopulationclinicalandimmunologicalevaluationduring12months AT meloalcinda poster1020efficacyandsafetyofsublingualspecificimmunotherapywithprup3inaportuguesepopulationclinicalandimmunologicalevaluationduring12months AT barbosamanuelpereira poster1020efficacyandsafetyofsublingualspecificimmunotherapywithprup3inaportuguesepopulationclinicalandimmunologicalevaluationduring12months AT santosconceicao poster1020efficacyandsafetyofsublingualspecificimmunotherapywithprup3inaportuguesepopulationclinicalandimmunologicalevaluationduring12months |